Evidence map›Paper›PMID 41392516›Full record

ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2026

Addiction and chronic skin diseases: A Pan-European study on prevalence, associations and patient impact.

Stefanie Ziehfreund, Magdalena Saak, Alisa Schaal, Roxana Mazilu, Emmanuel Mahé, Carla Hajj, Emma K Johansson, Josefin Lysell, Gunnthorunn Sigurdardottir, Franz J Legat and 64 more

Abstract readMulticenter Study
In one paragraph

Article in Journal of the European Academy of Dermatology and Venereology : JEADV, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Addiction and chronic skin diseases: The missing role of itch.Journal of the European Academy of Dermatology and Venereology : JEADV · 2026
    Article
  5. Addiction and chronic skin diseases: A Pan-European study on prevalence, associations and patient impact.Journal of the European Academy of Dermatology and Venereology : JEADV · 2026
    Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

74 authors.

Stefanie ZiehfreundDepartment of Dermatology and Allergy, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany.ORCID https://orcid.org/0000-0003-3176-1120
Magdalena SaakDepartment of Dermatology and Allergy, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany.
Alisa SchaalDepartment of Dermatology and Allergy, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany.
Roxana MaziluDepartment of Dermatology and Allergy, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany.
Emmanuel MahéDermatology Department, Centre Hospitalier Victor Dupouy, Argenteuil Cedex, France.ORCID https://orcid.org/0000-0001-5780-1827
Carla HajjDermatology Department, Centre Hospitalier Victor Dupouy, Argenteuil Cedex, France.
Emma K JohanssonDivision of Dermatology and Venereology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Josefin LysellDivision of Dermatology and Venereology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Gunnthorunn SigurdardottirDepartment of Dermatology and Venereology in Östergötland, Linköping University, Linköping, Sweden.
Franz J LegatDepartment of Dermatology, Medical University of Graz, Graz, Austria.ORCID https://orcid.org/0000-0002-7785-4739
Catherina KochDepartment of Dermatology, Medical University of Graz, Graz, Austria.
Astrid SchmiederDepartment of Dermatology, Venereology and Allergology, University Hospital Würzburg, Wurzburg, Germany.ORCID https://orcid.org/0000-0002-6421-9699
Caroline GlatzelDepartment of Dermatology, Venereology and Allergology, University Hospital Würzburg, Wurzburg, Germany.ORCID https://orcid.org/0000-0003-2974-8277
Brian KirbyCharles Department of Dermatology, St. Vincent's University Hospital, Dublin, Ireland.
Emily PenderCharles Department of Dermatology, St. Vincent's University Hospital, Dublin, Ireland.
Anna Zalewska-JanowskaPsychodermatology and Neuroimmunobiology of Skin Department, Medical University of Lodz, Łódź, Poland.
Katarzyna TomaszewskaPsychodermatology and Neuroimmunobiology of Skin Department, Medical University of Lodz, Łódź, Poland.
Giulia CiccareseUnit of Dermatology, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.ORCID https://orcid.org/0000-0001-8363-0195
Pia LauriolaUnit of Dermatology, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
Michael J BoffaDepartment of Dermatology, Mater Dei Hospital, Msida, Malta.
Stephanie FarrugiaDepartment of Dermatology, Mater Dei Hospital, Msida, Malta.ORCID https://orcid.org/0000-0001-6919-5692
Anna Caroline PilzDepartment of Dermatology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Franziska SchauerDepartment of Dermatology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.ORCID https://orcid.org/0000-0001-5147-0123
Magdalena TrzeciakDepartment of Dermatology, Venereology and Allergology, Faculty of Medicine, Medical University of Gdansk, Gdansk, Poland.
Weronika ZyskDepartment of Dermatology, Venereology and Allergology, Faculty of Medicine, Medical University of Gdansk, Gdansk, Poland.
Krisztián GáspárDepartment of Dermatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Andrea SzegediDepartment of Dermatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Giovanni DamianiDepartment of Biomedical, Surgical, and Dental Sciences, University of Milan, Milan, Italy.
Andrea CarugnoDermatology Unit, Department of Medicine and Surgery, University of Insubria, Varese, Italy.
Ilona HartmaneDepartment of Dermatology and Venerology, Riga Stradinš University, Riga, Latvia.
Ingmars MikazansDepartment of Skin and Venereal Diseases, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Skaidra ValiukevicieneDepartment of Skin and Venereal Diseases, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Livija PetrokaiteDepartment of Skin and Venereal Diseases, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Jacek C SzepietowskiDepartment of Dermato-Venerology, 4th Military Hospital, Wroclaw, Poland.ORCID https://orcid.org/0000-0003-0766-6342
Beata JastrząbUniversity Centre of General Dermatology and Oncodermatology, Wroclaw Medical University, Wroclaw, Poland.
Petra StaubachDepartment of Dermatology, University Medical Center Mainz, Mainz, Germany.
Suzana Ljubojević HadžavdićDepartment of Dermatology, University Medical Center Mainz, Mainz, Germany.ORCID https://orcid.org/0000-0002-3640-9567
Daška Štulhofer BuzinaDepartment of Dermatology and Venereology, University Hospital Center Zagreb, Zagreb, Croatia.
Christian PoschDepartment of Dermatology and Allergy, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany.
Jakob JochmannDepartment for Dermatology, Clinic Hietzing, Vienna Healthcare Group, Vienna, Austria.ORCID https://orcid.org/0000-0002-1204-1884
Antonia WialaDepartment for Dermatology and Venereology, Clinic Landstrasse, Vienna Healthcare Group, Vienna, Austria.
Ludwig ScheffenbichlerDepartment for Dermatology and Venereology, Clinic Donaustadt, Vienna Healthcare Group, Vienna, Austria.
Emanuele TrovatoDermatology Unit, Department of Medical, Surgical and Neurological Sciences, University of Siena, Siena, Italy.
Laura CalabreseDermatology Unit, Department of Medical, Surgical and Neurological Sciences, University of Siena, Siena, Italy.ORCID https://orcid.org/0000-0001-5238-2336
Gyula Laszlo FeketeDermatology Department, 'George Emil Palade' University of Medicine, Pharmacy, Science and Technology, Targu Mures, Romania.
Pavel ChernyshovDepartment of Dermatology and Venereology, National Medical University, Kiev, Ukraine.
Lidiia KolodzinskaKhmelnytskyi City Medical and Diagnostic Center, 2nd Polyclinic, Khmelnytskyi, Ukraine.
Julia WelzelDepartment of Dermatology and Allergology, Augsburg University Hospital, Augsburg, Germany.ORCID https://orcid.org/0000-0002-6099-7418
Karisa ThölkenDepartment of Dermatology and Allergology, Augsburg University Hospital, Augsburg, Germany.
Julia-Tatjana MaulFaculty of Medicine, University of Zürich, Zurich, Switzerland.ORCID https://orcid.org/0000-0002-9914-1545
Lara Valeska MaulFaculty of Medicine, University of Zürich, Zurich, Switzerland.
Damian MeyersburgDepartment of Dermatology and Allergology, University Hospital Salzburg of the Paracelsus Medical University, Salzburg, Austria.ORCID https://orcid.org/0000-0001-8339-6917
Stephanie BoweDepartment of Dermatology, South Infirmary Victoria Hospital, Cork, Ireland.ORCID https://orcid.org/0000-0002-4958-820X
Cathal O ConnorDepartment of Dermatology, South Infirmary Victoria Hospital, Cork, Ireland.ORCID https://orcid.org/0000-0001-7084-5293
Razvigor DarlenskiDepartment of Dermatology and Venereology, Trakia University, Stara Zagora, Bulgaria.ORCID https://orcid.org/0000-0002-4220-8040
Stephan TraidlDepartment of Dermatology and Allergy, Hannover Medical School, Hannover, Germany.ORCID https://orcid.org/0000-0003-4806-599X
Christian VestergaardDepartment of Dermatology, Aarhus University Hospital, Aarhus, Denmark.
Elena Lucía Pinto-PulidoDepartment of Dermatology, Hospital Universitario Príncipe de Asturias, Madrid, Spain.ORCID https://orcid.org/0000-0002-1075-5103
Maria Polina KonstantinouDepartment of Dermatology, University General Hospital of Heraklion, Heraklion, Greece.ORCID https://orcid.org/0000-0001-8171-6542
Eszter SzláviczDepartment of Dermatology, Venereology and Oncodermatology, Medical Faculty, University of Pécs, Pécs, Hungary.
Kristine HeidemeyerDepartment of Dermatology, Bern University Hospital, University of Bern, Inselspital, Switzerland.ORCID https://orcid.org/0000-0001-9217-6086
Nikhil YawalkarDepartment of Dermatology, Bern University Hospital, University of Bern, Inselspital, Switzerland.ORCID https://orcid.org/0000-0003-0024-338X
Hanka Agnes Caroline LantzschDepartment of Dermatology and Allergology, Asklepios Nordseeklinik Sylt/Westerland, Sylt OT Westerland, Germany.
Aleksandra SoplinskaDepartment of Dermatology, Medical University of Warsaw, Warsaw, Poland.
Anna-Theresa SeitzDepartment of Dermatology, Venerology and Allergology, Faculty of Medicine, Leipzig University, Leipzig, Germany.
Tiago TorresDepartment of Dermatology, Centro Hospitalar Universitário de Santo António, University of Porto, Porto, Portugal.ORCID https://orcid.org/0000-0003-0404-0870
Zenon BrzozaDepartment of Internal Diseases with Division of Allergology, University of Opole, Opole, Poland.ORCID https://orcid.org/0000-0002-1230-7013
Ana Sanader VučemilovićDepartment of Dermatovenerology, University Hospital Centre Split, Split, Croatia.ORCID https://orcid.org/0000-0002-9232-2634
Liana ManolacheDermatology, Dali Medical, Bucharest, Romania.
Nina MagnoloDepartment of Dermatology, University Hospital of Muenster, Münster, Germany.ORCID https://orcid.org/0000-0001-6802-0153
Emanuele ScalaLaboratory of Experimental Immunology, Istituto Dermopatico dell'Immacolata-Istituto di Ricovero e Cura a Carattere Scientifico (IDI-IRCCS), Rome, Italy.ORCID https://orcid.org/0000-0001-6848-3262
Kilian EyerichDepartment of Dermatology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.ORCID https://orcid.org/0000-0003-0094-2674
Tilo BiedermannDepartment of Dermatology and Allergy, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany.
Alexander ZinkDepartment of Dermatology and Allergy, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany.ORCID https://orcid.org/0000-0001-9313-6588

Funding

European Academy of Dermatology and Venereology PPRC-2022-19
6 · The paper itself

Abstract

backgroundChronic skin diseases such as psoriasis (PSO), atopic dermatitis (AD) and hidradenitis suppurativa (HS) are frequently associated with psychological distress, potentially promoting maladaptive coping mechanisms including addictive behaviours. Despite evidence of higher addiction rates among dermatology patients, comprehensive multicenter data across Europe are lacking.

objectivesTo estimate the prevalence and patterns of addictive behaviours among patients with chronic skin diseases in European tertiary dermatology centres and explore associated sociodemographic and clinical factors.

methodsThis multicentre cross-sectional study recruited adult patients with PSO, AD, HS, alopecia areata (AA), urticaria, or vitiligo from dermatology departments in 20 European countries. Participants completed a standardized questionnaire assessing sociodemographics, disease characteristics, and addictive behaviours (smoking, alcohol use, drug use, gambling, internet addiction, and eating disorders). Descriptive analyses and multivariate logistic regression were performed.

resultsAmong 3585 participants (median age 43 years; 51.1% female), the prevalence of addictive behaviours was notable: smoking (25.7%), pathological gambling (4.5%), hazardous drinking (8.8%), alcohol dependence (2.5%), drug use disorders (5.3%), eating disorders (1.8%), and internet addiction (29.7%). Smoking was most common among PSO and HS patients (48.6%), and gambling among AA and vitiligo patients (8.2%). Significant associations included male sex, younger age, single status, higher Dermatology Life Quality Index (DLQI) scores, and regional variation. DISCUSSION: Addictive behaviours are prevalent in dermatology patients and are associated with both sociodemographic and disease-related factors. The DLQI was positively correlated with multiple addictions, suggesting that reduced quality of life may contribute to maladaptive coping. However, due to the absence of a control group, the tertiary care setting, limited center distribution, and unknown response rate, generalizability is restricted.

conclusionsAddiction screening and supportive mental health strategies should be integrated into dermatologic care, particularly for high-risk patients. Population-based studies with control groups are needed to confirm these findings.

Indexed as

Behavior, AddictiveSkin DiseasesAdultAgedAlcoholismChronic DiseaseCross-Sectional StudiesDermatitis, AtopicEuropeFemaleGamblingHumansMaleMiddle AgedPrevalencePsoriasisaddictive behaviouralcohol useatopic dermatitiscomorbiditycross‐sectional studyEuropegamblingHidradenitis Suppurativainternet addictionpatient‐reported outcomespsoriasisquality of lifeskin diseasesstigmatizationurticariaVitiligo

Identifiers

PMID41392516
PMCPMC13425250

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.